Shree Ganesh Remedies Limited Share Price
Shree Ganesh Remedies Limited Share Price Today
As of 5 Jul 2026, Shree Ganesh Remedies Limited share price is ₹676.55. The stock opened at ₹644.25, compared to its previous close of ₹642.40. During today's trading session, Shree Ganesh Remedies Limited share price moved in the range of ₹641.20 to ₹681.00, with an average price of ₹661.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹381.10 and a high of ₹759.00.
Shree Ganesh Remedies Limited Returns Calculator
Shree Ganesh Remedies Limited Shareholder Returns
Shree Ganesh Remedies Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Shree Ganesh Remedies Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Revenue | ₹108.60 | ₹125.90 | ₹64.02 | ₹35.31 |
| Other Income | ₹3.73 | ₹3.07 | ₹3.91 | ₹1.17 |
| Total Revenue | ₹112.33 | ₹128.97 | ₹67.93 | ₹36.48 |
| Total Expenses | ₹81.06 | ₹90.81 | ₹54.34 | ₹27.81 |
| Profit Before Tax | ₹31.27 | ₹38.16 | ₹13.59 | ₹8.67 |
| Tax | ₹8.20 | ₹10.05 | ₹3.12 | ₹2.43 |
| Profit After Tax | ₹23.07 | ₹28.11 | ₹10.47 | ₹6.24 |
| EPS - Basic | ₹17.96 | ₹22.34 | ₹11.67 | ₹6.95 |
| EPS - Diluted | ₹17.96 | ₹22.34 | ₹11.67 | ₹6.95 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Profit before tax | ₹31.27 | ₹38.16 | ₹10.47 | ₹6.24 |
| Income before WC changes | ₹42.45 | ₹44.05 | ₹9.93 | ₹8.32 |
| Change in Assets | ₹0.45 | ₹1.41 | -₹9.82 | ₹26.70 |
| Change in Liabilities | -₹2.19 | -₹6.88 | ₹4.48 | -₹40.24 |
| Change in WC | -₹1.73 | -₹5.47 | -₹5.34 | -₹13.53 |
| Cash flow from Operations | ₹30.66 | ₹30.45 | ₹4.59 | -₹5.22 |
| Cash flow from Investing | -₹35.66 | -₹33.01 | -₹2.91 | -₹0.08 |
| Cash flow from Financing | -₹1.09 | ₹9.84 | -₹0.48 | -₹0.18 |
| Total Cash Flow | -₹6.08 | ₹7.28 | ₹1.20 | -₹5.47 |
| Cash (Start of the year) | ₹15.85 | ₹8.66 | ₹1.13 | ₹6.46 |
| Cash (End of the year) | ₹9.95 | ₹15.85 | ₹2.33 | ₹0.99 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Non-Current Assets | ₹114.37 | ₹100.73 | ₹21.46 | ₹15.53 |
| Current Assets | ₹77.58 | ₹70.20 | ₹33.82 | ₹25.81 |
| Total Assets | ₹191.94 | ₹170.94 | ₹55.28 | ₹41.34 |
| Current Liabilities | ₹16.18 | ₹18.68 | ₹10.38 | ₹6.79 |
| Net Current Asset | ₹61.39 | ₹51.52 | ₹23.44 | ₹19.02 |
| Non-Current Liabilities | ₹30.60 | ₹30.16 | ₹2.65 | ₹0.73 |
| Equity Capital | ₹145.16 | ₹122.10 | ₹42.25 | ₹33.82 |
| Total Equity & Liabilities | ₹191.94 | ₹170.94 | ₹55.28 | ₹41.34 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹108.60 | ₹125.90 | ₹91.36 | ₹71.29 |
| Other Income | ₹3.73 | ₹3.07 | ₹0.72 | ₹3.57 |
| Total Revenue | ₹112.33 | ₹128.97 | ₹92.07 | ₹74.86 |
| Total Expenses | ₹81.03 | ₹90.80 | ₹71.84 | ₹56.85 |
| Profit Before Tax | ₹31.30 | ₹38.17 | ₹20.24 | ₹18.01 |
| Tax | ₹8.20 | ₹10.05 | ₹5.05 | ₹4.61 |
| Profit After Tax | ₹23.10 | ₹28.12 | ₹15.18 | ₹13.40 |
| EPS - Basic | ₹17.98 | ₹22.35 | ₹12.54 | ₹10.96 |
| EPS - Diluted | ₹17.98 | ₹22.35 | ₹12.54 | ₹10.96 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹31.30 | ₹38.17 | ₹20.24 | ₹18.01 |
| Income before WC changes | ₹42.45 | ₹44.05 | ₹26.72 | ₹15.52 |
| Change in Assets | ₹0.46 | ₹1.41 | -₹11.23 | -₹8.70 |
| Change in Liabilities | -₹2.19 | -₹6.88 | ₹1.61 | ₹6.60 |
| Change in WC | -₹1.73 | -₹5.47 | -₹9.62 | -₹2.10 |
| Cash flow from Operations | ₹30.66 | ₹30.45 | ₹17.10 | ₹13.42 |
| Cash flow from Investing | -₹35.66 | -₹33.09 | -₹51.09 | -₹11.91 |
| Cash flow from Financing | -₹1.06 | ₹9.85 | ₹38.66 | -₹1.09 |
| Total Cash Flow | -₹6.05 | ₹7.21 | ₹4.67 | ₹0.42 |
| Cash (Start of the year) | ₹15.78 | ₹8.66 | ₹3.88 | ₹3.47 |
| Cash (End of the year) | ₹9.90 | ₹15.78 | ₹8.66 | ₹3.88 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹114.45 | ₹100.82 | ₹75.75 | ₹32.11 |
| Current Assets | ₹77.53 | ₹70.13 | ₹62.22 | ₹44.91 |
| Total Assets | ₹191.98 | ₹170.94 | ₹137.97 | ₹77.02 |
| Current Liabilities | ₹16.18 | ₹18.68 | ₹20.11 | ₹15.04 |
| Net Current Asset | ₹61.35 | ₹51.45 | ₹42.11 | ₹29.87 |
| Non-Current Liabilities | ₹30.60 | ₹30.16 | ₹30.66 | ₹0.40 |
| Equity Capital | ₹145.19 | ₹122.11 | ₹87.20 | ₹61.57 |
| Total Equity & Liabilities | ₹191.98 | ₹170.94 | ₹137.97 | ₹77.02 |
About Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited is an India-based company, which is engaged in the business of bulk drug intermediates. The Company's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. Its human health API intermediates include antipsychotic, antidepression, oncology, diabetic, and diuretic. Its specialty & fine chemicals include aroma & health industry, agro-industry, polymer industry, and electronics industry. Its veterinary API intermediates include feed additives, antiparasitic, and anti-inflammatory. Its anti-arrhythmic API intermediates include amiodarone intermediates, dronedarone intermediates, and mesalazine intermediates. Its anti-cancer API intermediates include cabozantinib intermediates, gefitinib intermediates, olaparib intermediates, and raloxifene intermediates. Its anti-parasitic API intermediates include flubendazole intermediates, nitazoxanide intermediates, and praziquantel intermediates.
Shree Ganesh Remedies Limited Financial Highlights
- Revenue: Shree Ganesh Remedies Limited reported revenue of ₹112.32 crore in FY26 vs ₹112.33 crore in FY25. It showed a decrease of 0.01% on a yearly basis.
- Operating Profit: Shree Ganesh Remedies Limited reported an operating profit of ₹24.01 crore in FY26 vs ₹31.27 crore in FY25. It showed a decrease of 23.22% on a year-on-year basis.
- Net Profit: Shree Ganesh Remedies Limited reported a net profit of ₹17.76 crore in FY26 vs ₹23.07 crore in FY25. It showed a decrease of 23.02% on a yearly basis.
Shree Ganesh Remedies Limited Quarterly Result Highlights
- Shree Ganesh Remedies Limited reported revenue of ₹34.22 crore in Mar 2026, compared with ₹21.77 crore in Dec 2025, representing an increase of 57.19% on a quarter-on-quarter (QoQ) basis.
- Shree Ganesh Remedies Limited reported an operating profit of ₹8.72 crore in Mar 2026, compared with ₹3.98 crore in Dec 2025, representing an increase of 119.10% on a quarter-on-quarter (QoQ) basis.
- Shree Ganesh Remedies Limited reported a profit of ₹6.27 crore in Mar 2026, compared with ₹3.09 crore in Dec 2025, reflecting an increase of 102.91% on a QoQ basis.
- The earnings per share (EPS) of Shree Ganesh Remedies Limited stood at ₹17.96 during Mar 2026.
Similar Stocks
FAQs on Shree Ganesh Remedies Limited Share Price
What is Shree Ganesh Remedies Limited share price today?
Shree Ganesh Remedies Limited share price is ₹676.55 as on 03 Jul, 2026, 15:29 IST.
How has the Shree Ganesh Remedies Limited share price performed in the past?
In the last 1 year, Shree Ganesh Remedies Limited delivered a return of 17.91%. The Shree Ganesh Remedies Limited share price hit a high of ₹759.00 and low of ₹381.10.
How much is the Mutual Fund shareholding in Shree Ganesh Remedies Limited shares?
The Mutual Fund Shareholding in Shree Ganesh Remedies Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Shree Ganesh Remedies Limited shares ?
The 52-week high and low of Shree Ganesh Remedies Limited share is ₹759.00 and ₹381.10 as of 03 Jul, 2026.
What is the market cap of Shree Ganesh Remedies Limited?
The market capitalisation of Shree Ganesh Remedies Limited is ₹824.69 Crores as on 03 Jul, 2026.
What are the stock symbols of Shree Ganesh Remedies Limited?
The stock symbol of Shree Ganesh Remedies Limited is 540737 on the BSE, and the ISIN is INE414Y01015.
What was yesterday's closing price for Shree Ganesh Remedies Limited shares ?
Shree Ganesh Remedies Limited shares closed yesterday at ₹642.40 on BSE
How to buy Shree Ganesh Remedies Limited shares?
To buy Shree Ganesh Remedies Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Shree Ganesh Remedies Limited shares on Holidays?
No, shares of Shree Ganesh Remedies Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Shree Ganesh Remedies Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Shree Ganesh Remedies Limited?
The PE and PB ratio of Shree Ganesh Remedies Limited is 46.45 and 5.06 respectively, as on 03 Jul, 2026, 15:29 IST.